Prefrontal Cortex
Introduction
Prefrontal cortex is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The prefrontal cortex (PFC) is the anterior portion of the frontal lobe, occupying the largest proportion of the frontal cortex and constituting nearly one-third of the total neocortical surface area in humans. It is the most recently evolved region of the cerebral cortex, reaching its greatest relative size and complexity in primates, particularly humans. The PFC is the neural substrate for the highest cognitive functions, including executive function, working memory, decision-making, attention, planning, personality expression, social behavior modulation, and impulse control ([Fuster, 2001](https://pubmed.ncbi.nlm.nih.gov/11584909/); [Miller & Cohen, 2001](https://pubmed.ncbi.nlm.nih.gov/11283309/)). [@miller2001]
The prefrontal cortex holds critical importance in neurodegenerative disease research because it is differentially affected across multiple disorders. In [FTD](/diseases/frontotemporal-dementia), the PFC is among the earliest and most severely affected regions, driving the hallmark behavioral and personality changes that define the disease. In [Alzheimer's disease](/diseases/alzheimers-disease), the PFC is affected in later Braak stages (stages IV–VI) as tau pathology spreads from the [entorhinal cortex](/brain-regions/entorhinal-cortex) and temporal lobe to neocortical association areas. The PFC is also implicated in [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](diseases/huntingtons), [PSP](/diseases/progressive-supranuclear-palsy), and [corticobasal degeneration](/diseases/corticobasal-degeneration), with distinct patterns of regional vulnerability contributing to the diverse clinical presentations of these conditions ([Rosen et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12177198/); [Braak et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16855773/)). [@rosen2002]
Anatomy and Cytoarchitecture
Location and Boundaries
The prefrontal cortex occupies the rostral pole of the frontal lobe, situated anterior to the premotor cortex (Brodmann area 6) and primary motor cortex (Brodmann area 4). It is bounded posteriorly by the precentral sulcus, medially by the longitudinal fissure, and inferiorly by the orbital surface above the orbits. In humans, the PFC encompasses Brodmann areas 8, 9, 10, 11, 12, 13, 14, 24, 25, 32, 44, 45, 46, and 47, representing an expansive territory with diverse cytoarchitecture and connectivity patterns ([Petrides, 2005](https://pubmed.ncbi.nlm.nih.gov/16043340/)). [@braak2006]
Major Subdivisions
The PFC is organized into several functionally and anatomically distinct subdivisions: [@petrides2005]
Dorsolateral Prefrontal Cortex (dlPFC)
The dorsolateral PFC (Brodmann areas 9, 46, and portions of 8 and 10) occupies the lateral surface of the superior and middle frontal gyri. It is the neural substrate for: [@refa]
- Working memory: Maintenance and manipulation of information over short time periods. Seminal electrophysiological studies by Goldman-Rakic demonstrated sustained neuronal firing in dlPFC during the delay period of working memory tasks, establishing the dlPFC as the "sketchpad" of the mind ([Goldman-Rakic, 1995](https://pubmed.ncbi.nlm.nih.gov/7624304/))
- Executive attention: Top-down attentional control and selective attention
- Cognitive flexibility: Set-shifting and the ability to adapt behavior based on changing rules or contingencies
- Planning and reasoning: Complex problem solving, strategic planning, and abstract reasoning
- Decision-making: Integration of multiple information streams to guide goal-directed behavior
The ventromedial PFC (Brodmann areas 10, 11, 12, 14, 25, and 32) encompasses the medial orbital and medial surface of the frontal lobe. Its primary functions include: [@damasio1996]
- Value-based decision-making: Assigning subjective value to stimuli and outcomes, critical for reward processing and economic decision-making
- Emotional regulation: Integration of emotional information into decision processes. The somatic marker hypothesis proposed by Damasio posits that the vmPFC integrates bodily (somatic) signals into decision-making processes ([Damasio, 1996](https://pubmed.ncbi.nlm.nih.gov/8713554/))
- Self-referential processing: Self-evaluation, introspection, and autobiographical memory retrieval
- Social cognition: Theory of mind, empathy, and moral reasoning
- Fear extinction: Regulation of conditioned fear responses through top-down modulation of the amygdala
Orbitofrontal Cortex (OFC)
The orbitofrontal cortex (Brodmann areas 10, 11, and 47) lies on the ventral surface of the frontal lobe above the orbital plates. It is critical for: [@seeley2009]
- Reward processing: Encoding the reward value of sensory stimuli, including food, social rewards, and monetary incentives
- Reversal learning: Updating stimulus-outcome associations when contingencies change
- Impulse control: Inhibiting prepotent responses and suppressing inappropriate behavior
- Emotion regulation: Modulating limbic system outputs to regulate emotional responses
Anterior Cingulate Cortex (ACC)
While sometimes classified separately, the anterior cingulate cortex (Brodmann areas 24, 25, 32, and 33) is functionally integrated with the PFC and contributes to: [@rascovsky2011]
- Conflict monitoring: Detecting conflicts between competing response tendencies
- Error detection: Signaling errors and violations of expectation
- Motivation and effort: Allocating cognitive resources based on cost-benefit analysis
- Pain processing: The dorsal ACC is involved in the affective-motivational component of pain perception
Connectivity
The PFC is the most extensively interconnected region of the cerebral cortex, receiving and sending projections to virtually every other cortical and subcortical structure: [@braak1991]
- Cortical connections: Reciprocal connections with temporal, parietal, and occipital association cortices; strong connections with hippocampal formation via the entorhinal-cortex and parahippocampal cortex
- Subcortical connections: Projections to and from the basal-ganglia (especially striatum), [thalamus (especially mediodorsal nucleus), amygdala, hypothalamus, and brainstem monoamine nuclei
- Neurotransmitter inputs: Receives major modulatory inputs including dopaminergic projections from the ventral tegmental area, serotonergic projections from the raphe nuclei, noradrenergic projections from the locus-coeruleus, and cholinergic projections from the nucleus-basalis-of-meynert
This extensive connectivity underlies the PFC's role as a "neural hub" that integrates information from diverse brain systems to guide complex behavior ([Fuster, 2001](https://pubmed.ncbi.nlm.nih.gov/11584909/)). [@ossenkoppele2015]
Role in Neurodegenerative Diseases
Frontotemporal Dementia
The prefrontal cortex is the primary site of neurodegeneration in the behavioral variant of ftd (bvFTD), which accounts for approximately 50–60% of all FTD cases. The hallmark clinical features of bvFTD — early personality changes, disinhibition, apathy, loss of empathy, compulsive behaviors, and impaired executive function — directly reflect dysfunction of specific PFC subregions: [@ossenkoppele2022]
- Disinhibition and impulsivity: Orbitofrontal cortex degeneration disrupts impulse control and social behavioral norms
- Apathy and loss of motivation: Anterior cingulate and dorsomedial PFC degeneration impairs motivation and goal-directed behavior
- Loss of empathy and social cognition: Ventromedial PFC and anterior insula degeneration disrupts theory of mind and emotional processing
- Executive dysfunction: Dorsolateral PFC involvement leads to impaired planning, reasoning, and cognitive flexibility
Neuropathologically, bvFTD is associated with frontotemporal lobar degeneration (FTLD), which may involve accumulations of tau (FTLD-tau, tdp-43 (FTLD-TDP), or fus (FTLD-FUS) protein aggregates. The distribution of these proteinopathies within the PFC varies by pathological subtype but consistently targets the frontal and insular cortices early in the disease course ([Seeley et al., 2009](https://pubmed.ncbi.nlm.nih.gov/19332184/); [Rascovsky et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21903914/)). [@williamsgray2009]
Alzheimer's Disease
In alzheimers (AD), the prefrontal cortex is affected later than the medial temporal lobe structures but becomes progressively involved as the disease advances: [@boxer2006]
- Braak stage I–II: tau-protein pathology is confined to the transentorhinal and entorhinal-cortex; PFC is largely spared
- Braak stage III–IV: Tau pathology spreads to the hippocampus, limbic structures, and early neocortical areas including the inferior temporal cortex; frontal lobe involvement begins with the insular cortex and basal frontal regions
- Braak stage V–VI: Widespread neocortical tau pathology engulfs the PFC, including dorsolateral, ventromedial, and orbitofrontal regions
amyloid-beta plaque deposition follows a different spatial pattern than tau, accumulating in the PFC relatively early (Thal phase 1) even before hippocampal involvement. This dissociation between early amyloid deposition and later tau pathology in the PFC has been confirmed by amyloid-pet and tau PET imaging studies ([Braak & Braak, 1991](https://pubmed.ncbi.nlm.nih.gov/1759558/); [Ossenkoppele et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35164467/)). [@bartzokis2004]
Young-onset alzheimers (onset before age 65) often presents with a "frontal" or dysexecutive phenotype, with disproportionate tau burden in the frontal regions and prominent executive dysfunction rather than the typical memory-predominant presentation of late-onset AD. This frontal variant of AD can be clinically challenging to distinguish from bvFTD ([Ossenkoppele et al., 2015](https://pubmed.ncbi.nlm.nih.gov/26497864/)). [@morrison2012]
Parkinson's Disease
In parkinsons, prefrontal cortex dysfunction contributes to the cognitive impairment and dementia that affect 80% of patients over the disease course: [@refb]
- Dopaminergic depletion: The mesocortical dopamine pathway from the ventral tegmental area to the PFC degenerates in PD, leading to prefrontal hypodopaminergia. This directly impairs executive function, working memory, and attention
- alpha-synuclein pathology: alpha-synuclein Lewy body pathology spreads to the prefrontal cortex in Braak PD stages 5–6, correlating with the development of parkinsons dementia
- Cholinergic depletion: Loss of cholinergic projections from the nucleus-basalis-of-meynert to the PFC compounds cognitive deficits
Functional neuroimaging studies consistently demonstrate prefrontal hypoactivation during executive tasks in PD patients, particularly in the dorsolateral PFC, with the degree of hypoactivation correlating with severity of cognitive impairment ([Williams-Gray et al., 2009](https://pubmed.ncbi.nlm.nih.gov/19744958/)).
Progressive Supranuclear Palsy
psp (PSP) involves prominent frontal lobe dysfunction, with severe executive impairment, behavioral changes, and apathy often preceding the classic motor features. The dorsal midbrain and frontal lobe atrophy characteristic of PSP produces a "subcortical-frontal" cognitive profile with impaired verbal fluency, set-shifting, and response inhibition ([Boxer et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16648500/)).
Corticobasal Degeneration
corticobasal-degeneration (CBD) frequently involves asymmetric frontoparietal cortical degeneration, with prominent involvement of the PFC leading to executive dysfunction, apraxia, and behavioral changes. The frontal variant of CBD may present similarly to bvFTD, highlighting the overlap between frontotemporal spectrum disorders.
Selective Vulnerability
Several factors contribute to the selective vulnerability of the PFC to neurodegenerative processes. See [DLPFC Executive Dysfunction in AD](/mechanisms/dorsolateral-prefrontal-cortex-executive-dysfunction) for a detailed mechanistic model of how tau pathology, layer-specific neuronal loss, and synaptic damage produce executive impairment in Alzheimer's disease. [@bartzokis2004]
Late myelination: The PFC is the last cortical region to fully myelinate, with development continuing into the third decade of life. The "first in, last out" hypothesis suggests that late-myelinating regions are among the first affected by age-related and neurodegenerative processes ([Bartzokis, 2004](https://pubmed.ncbi.nlm.nih.gov/15380012/))
High metabolic demand: The PFC has among the highest metabolic rates of any brain region, making it particularly susceptible to mitochondrial-dysfunction, oxidative-stress, and energy failure
Dopaminergic vulnerability: The mesocortical dopamine pathway is particularly susceptible to oxidative damage, and dopamine catabolism generates oxidative-stress that contribute to cellular stress
Network hub vulnerability: As a major network hub with extensive connectivity, the PFC is exposed to pathological protein propagation through prion-like-spreading mechanisms along connected neural circuits
Excitatory-inhibitory imbalance: Age-related loss of GABAergic interneurons in the PFC disrupts the excitatory-inhibitory balance, potentially increasing vulnerability to excitotoxicity and neurodegeneration([Morrison & Baxter, 2012](https://pubmed.ncbi.nlm.nih.gov/22632727/))
Aging and the Prefrontal Cortex
The PFC is disproportionately affected by normal aging, showing greater age-related volume loss than most other cortical regions. Age-related changes in the PFC include:
- Synaptic loss: Reduction in dendritic spine density, particularly in layer III pyramidal neurons, with up to 30–50% spine loss by age 80
- White matter degeneration: Myelin breakdown and loss of cortical white matter volume, disrupting prefrontal-subcortical circuits
- Neurotransmitter decline: Progressive reduction in dopamine, serotonin, norepinephrine, and acetylcholine levels, contributing to age-related cognitive decline
- Inflammation: Increased microglial(https://pubmed.ncbi.nlm.nih.gov/15140939/); [Morrison & Baxter, 2012](https://pubmed.ncbi.nlm.nih.gov/22632727/)).
Clinical Assessment of Prefrontal Function
Assessment of prefrontal cortex function is critical in the clinical evaluation of neurodegenerative diseases:
- Wisconsin Card Sorting Test: Assesses cognitive flexibility and set-shifting (dlPFC function)
- Trail Making Test Part B: Evaluates executive attention and task-switching
- Verbal fluency tests: Phonemic (letter) fluency is sensitive to dorsolateral PFC lesions; semantic (category) fluency involves temporal lobe-PFC networks
- Stroop Color-Word Test: Measures inhibitory control and selective attention
- Iowa Gambling Task: Assesses value-based decision-making under uncertainty (vmPFC function)
- Go/No-Go and Stop Signal tasks: Evaluate response inhibition (right inferior frontal gyrus)
- Frontal Assessment Battery (FAB): A brief bedside screening tool for frontal lobe dysfunction
Neuroimaging provides complementary assessment:
- Structural MRI: Quantifies prefrontal atrophy patterns that help differentiate between FTD, AD, and other neurodegenerative conditions
- FDG-PET: Frontal hypometabolism is a hallmark of bvFTD, contrasting with the biparietal and posterior temporal hypometabolism of typical AD
- Tau PET: Maps the distribution of tau pathology across prefrontal subregions
- [Cortical Pyramidal [Neurons (Layers 2/3)/cell-types/[cortical-pyramidal-l2-3](/cell-types/neurons)
Background
The study of Prefrontal cortex has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Brain Atlas Resources
This section links to atlas resources relevant to this brain region.
- Allen Human Brain Atlas: [Prefrontal Cortex expression search](https://human.brain-map.org/microarray/search/show?search_term=Prefrontal+Cortex)
- Allen Mouse Brain Atlas: [Prefrontal Cortex search](https://mouse.brain-map.org/search/index.html?query=Prefrontal+Cortex)
- Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
- BrainSpan Developmental Transcriptome: [Prefrontal Cortex developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Prefrontal+Cortex)
Prefrontal Cortex Connectivity
Mermaid diagram (expand to render)
Prefrontal Subregions and Function
| Region | Function | Dysfunction in Aging/AD |
|--------|----------|--------------------------|
| Dorsolateral (dlPFC) | Working memory, planning | Impaired executive function |
| Ventromedial (vmPFC) | Emotion regulation, reward | Emotional blunting |
| Orbitofrontal (OFC) | Decision making, inhibition | Disinhibition, impulsivity |
| Anterior Cingulate | Motivation, conflict monitoring | Apathy, abulia |
References
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/11584909/)
[Unknown, Miller, E.K., & Cohen, J.D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202. [PubMed) (2001)](https://pubmed.ncbi.nlm.nih.gov/11283309/)
[Rosen, H.J., Gorno-Tempini, M.L., Goldman, W.P., et al., (2002). Patterns of brain atrophy in Frontotemporal Dementia and semantic dementia. Neurology, 58(2), 198–208. [PubMed) (2002)](https://pubmed.ncbi.nlm.nih.gov/12177198/)
[Unknown, Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006). Staging of Alzheimer's Disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica, 112(4), 389–404. [PubMed) (2006)](https://pubmed.ncbi.nlm.nih.gov/16855773/)
[Unknown, Petrides, M. (2005). Lateral prefrontal cortex: architectonic and functional organization. Philosophical Transactions of the Royal Society B, 360(1456), 781–795. [PubMed) (2005)](https://pubmed.ncbi.nlm.nih.gov/16043340/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/7624304/)
[Unknown, Damasio, A.R. (1996). The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philosophical Transactions of the Royal Society B, 351(1346), 1413–1420. [PubMed) (1996)](https://pubmed.ncbi.nlm.nih.gov/8713554/)
[Seeley, W.W., Crawford, R., Rascovsky, K., et al., (2009). Frontal paralimbic network atrophy in very mild behavioral variant Frontotemporal Dementia. Archives of Neurology, 65(2), 249–255. [PubMed) (2009)](https://pubmed.ncbi.nlm.nih.gov/19332184/)
[Rascovsky, K., Hodges, J.R., Knopman, D., et al., (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of Frontotemporal Dementia. Brain, 134(Pt 9), 2456–2477. [PubMed) (2011)](https://pubmed.ncbi.nlm.nih.gov/21903914/)
[Unknown, Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239–259. [PubMed) (1991)](https://pubmed.ncbi.nlm.nih.gov/1759558/)
[Ossenkoppele, R., Schonhaut, D.R., Schöll, M., et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26497864/)
[Unknown, Ossenkoppele, R., Hansson, O., & Schöll, M. (2022). Tau biomarkers in Alzheimer's Disease: towards implementation in clinical practice and trials. The Lancet Neurology, 21(8), 726–734. [PubMed) (2022)](https://pubmed.ncbi.nlm.nih.gov/35164467/)
[Williams-Gray, C.H., Foltynie, T., Brayne, C.E.G., et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19744958/)
[Boxer, A.L., Geschwind, M.D., Belfor, N., et al., (2006). Patterns of brain atrophy that differentiate Corticobasal Degeneration syndrome from Progressive Supranuclear Palsy. Archives of Neurology, 63(1), 81–86. [PubMed) (2006)](https://pubmed.ncbi.nlm.nih.gov/16648500/)
[Unknown, Bartzokis, G. (2004). Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's Disease. Neurobiology of Aging, 25(1), 5–18. [PubMed) (2004)](https://pubmed.ncbi.nlm.nih.gov/15380012/)
[Unknown, Morrison, J.H., & Baxter, M.G. (2012). The ageing cortical synapse: hallmarks and implications for cognitive decline. Nature Reviews Neuroscience, 13(4), 240–250. [PubMed) (2012)](https://pubmed.ncbi.nlm.nih.gov/22632727/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15140939/)